GlassScriptPhysician profile
Emilio Robles
NPI 1720641103
$5,636.94
in general payments reported to CMS, 2019-2025
12 companies · $1,199 in 2025
The $1,199 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,200 · 2022: $197 · 2023: $2,219 · 2024: $822 · 2025: $1,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,056 · Travel and Lodging: $1,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,055.73 |
| Travel and Lodging | $1,184.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,990.20 | 2022-2025 | Pro, T2 Alpha, Gamma |
| Micromed INC | $1,200.00 | 2021 | |
| Smith+Nephew, INC. | $316.98 | 2025 | Evos, Pico 14, Pico |
| Cornerstone Medical Associates, INC. | $227.41 | 2023-2024 | |
| Skeletal Dynamics INC | $184.72 | 2025 | Ijs, Geminus, Align |
| Depuy Synthes Sales INC. | $136.36 | 2024 | Motoband, Na |
| Octapharma USA, INC. | $134.46 | 2025 | Fibryga |
| Medtronic, INC. | $133.97 | 2023 | Prestige LP Cervical Disc System |
| My01 INC. | $127.35 | 2025 | My01 Continuous Compartmental Pressure Monitor |
| Axogen | $122.72 | 2024 | Axoguard Nerve Cap, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Bone Support INC. | $46.50 | 2024 | Cerament G, Ceramentbone Void Filler |
| Vertex Pharmaceuticals Incorporated | $16.27 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emilio Robles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.